Faculty hosts 12th International Conference on Cerebral Vascular Biology

Faculty hosts 12th International Conference on Cerebral Vascular Biology

28 November 2017

The Faculty of Pharmacy and Pharmaceutical Sciences is delighted to today welcome 220 delegates from 25 countries around the globe for the 12th International Conference on Cerebral Vascular Biology (CVB 2017).

This is the first time in the 25 years of the conference that this number of scientists and clinicians will congregate in the Southern Hemisphere.

The conference is an international forum for scientists to discuss the latest research on cerebral vascular biology. A particular focus will be placed on the blood-brain barrier and blood-cerebrospinal fluid-barrier and how they play a crucial role in both homeostasis and central nervous system disease processes.

The conference will showcase 11 symposia including development of the brain barriers, drug transport and delivery across the barriers, the role of brain barriers in the aetiology of neurological diseases, and therapeutic strategies to reverse these diseases by targeting these barriers.

“It is an immense honour to welcome my colleagues around the world to this exciting event and to be able to showcase the fantastic research being undertaken both here at Monash and worldwide,” said conference Chair, Dr Joseph Nicolazzo from the Monash Institute of Pharmaceutical Sciences.

“The role of the blood-brain barrier and blood-cerebrospinal fluid-barrier in physiology and pathology is becoming one of the hottest topics in neuroscience, and I am excited to hear what new discoveries have been made in this space from the many international delegates,” he said.

The conference was opened with a plenary lecture provided by Professor Lester Drewes from the University of Minnesota. Professor Drewes is the immediate Past-President of International Brain Barriers Society. He will provide an overview of the landscape of brain barriers and thoughts on how this field of research will take us to the next frontier of medicines discovery.

The closing plenary will be provided by Professor Cheryl Wellington from the University of British Columbia, who will describe her recent work on targets at the blood-brain barrier which may be exploited for reversal of Alzheimer’s disease.

This exciting conference program will be complemented by 120 poster presentations from leading experts and early career researchers from around the globe.

The conference is being held on the Monash University Parvkille campus from Tuesday, 28 November to Friday, 1 December 2017.

For further information see www.cvb2017.org